Ticker Symbol: TOS/TSX
Shares Outstanding: 57,939,451
QUEBEC CITY, Aug. 11 /CNW Telbec/ - TSO3 Inc. ("TSO3") (TSX: TOS), an innovator in sterilization technology for medical devices in healthcare settings, announced today that Mr. R.M. (Ric) Rumble, CEO of the Company, will present on TSO3 at the 30th Annual Canaccord Genuity Growth Conference, at the InterContinental Hotel in Boston, Massachusetts.
TSO3's presentation will take place today, Wednesday, August 11, 2010 at 4:00 p.m. (EDT). The slide presentation and a link to an audio webcast of the event will be available until November 7 at http://www.wsw.com/webcast/canaccord2/tos.to/.
TSO3, founded in Québec City in 1998, specializes in the research and development of innovative, high-performance medical instrument sterilization technology with high commercial potential. TSO3 designs products for sterile processing areas in the hospital environment and offers an advantageous replacement solution to other low temperature sterilization processes currently used in hospitals.
For more information about TSO3, visit the Company's Web site at www.tso3.com.
The statements in this release and oral statements made by representatives of TSO3 relating to matters that are not historical facts (including, without limitation, those regarding the timing or outcome of any financing undertaken by TSO3) are forward-looking statements that involve certain risks, uncertainties and hypotheses, including, but not limited to, general business and economic conditions, the condition of the financial markets, the ability of TSO3 to obtain financing on favourable terms and other risks and uncertainties.
The TSX has neither approved nor disapproved the information contained herein and accepts no responsibility for it.
SOURCE TSO3 Inc.
For further information: For further information: Caroline Côté, Director, Corporate Communications and Investor Relations, 418 651-0003, Ext. 237, email@example.com; Source: TSO3 Inc.